Major T-cell responses in multiple sclerosis
Open Access
- 1 May 1995
- journal article
- review article
- Published by Elsevier in Molecular Medicine Today
- Vol. 1 (2) , 79-83
- https://doi.org/10.1016/s1357-4310(95)92366-7
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production.The Journal of Experimental Medicine, 1994
- Anti‐myelin basic protein and anti‐proteolipid protein specific forms of multiple sclerosisAnnals of Neurology, 1994
- Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.The Journal of Experimental Medicine, 1994
- Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones.The Journal of Experimental Medicine, 1994
- Selection for T-cell receptor Vβ–Dβ–Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosisNature, 1993
- Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.Journal of Clinical Investigation, 1993
- Amelioration of Autoimmune Encephalomyelitis by Myelin Basic Protein Synthetic Peptide-Induced AnergyScience, 1992
- T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosisNature, 1990
- Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapyCell, 1989
- Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune interventionCell, 1988